On minimising tumoural growth under treatment resistance
From MaRDI portal
Publication:6136591
DOI10.1016/J.JTBI.2023.111716zbMATH Open1530.92089OpenAlexW4389990235MaRDI QIDQ6136591FDOQ6136591
Authors: Matthias M. Fischer, Nils Blüthgen 
Publication date: 17 January 2024
Published in: Journal of Theoretical Biology (Search for Journal in Brave)
Full work available at URL: https://doi.org/10.1016/j.jtbi.2023.111716
Recommendations
- Tumor containment: a more general mathematical analysis
- Why is evolution important in cancer and what mathematics should be used to treat cancer? Focus on drug resistance
- On drug resistance and metronomic chemotherapy: a mathematical modeling and optimal control approach
- An adaptive pharmacokinetic optimal control approach in chemotherapy for heterogeneous tumor
Cites Work
- A 3-compartment model for chemotherapy of heterogeneous tumor populations
- Populational adaptive evolution, chemotherapeutic resistance and multiple anti-cancer therapies
- Evolution of resistance to anti-cancer therapy during general dosing schedules
- Emergence of anti-cancer drug resistance: exploring the importance of the microenvironmental niche via a spatial model
- The impact of cell density and mutations in a model of multidrug resistance in solid tumors
- A stochastic model for the origin and treatment of tumors containing drug-resistant cells
- Modeling the effects of space structure and combination therapies on phenotypic heterogeneity and drug resistance in solid tumors
- Drug resistance in cancer chemotherapy as an optimal control problem
- Stochastic modeling of cellular colonies with quiescence: an application to drug resistance in cancer
Cited In (3)
This page was built for publication: On minimising tumoural growth under treatment resistance
Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q6136591)
